Home › Funds › Integral Health Asset Management, LLC › CYTK

Integral Health Asset Management, LLC position in CYTK

CYTOKINETICS INC · Health Care

Integral Health Asset Management, LLC reported holding 1,600,000 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$72.5M, representing 4.70% of its reported portfolio and ranking #3 among its reported holdings. Integral Health Asset Management, LLC has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.60M sh
Reported value held$72.50M
Portfolio Weight4.70%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's CYTK position evolved

Integral Health Asset Management, LLC first disclosed a stake in CYTK in Q3 2023 at 800,000 shares (US$23.6M). The position peaked in Q2 2026 at 1,600,000 shares, worth US$136.3M. Across 13 filings, Integral Health Asset Management, LLC increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,600,000 shares valued at US$72.5M. Notable position changes include a 350% increase in Q1 2024 (shares fell 23% over the following quarter), a 122% increase in Q2 2024 (shares fell 3% over the following quarter), a 100% increase in Q1 2026 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 800.00K $23.57M New
Q4 2023 100.00K $8.35M Reduce
Q1 2024 450.00K $31.55M Add
Q2 2024 1.00M $54.18M Add
Q3 2024 750.00K $39.60M Reduce
Q4 2024 1.00M $47.04M Add
Q1 2025 1.10M $44.21M Add
Q2 2025 500.00K $16.52M Reduce
Q3 2025 750.00K $41.22M Add
Q4 2025 500.00K $31.77M Reduce
Q1 2026 1.00M $65.91M Add
Q2 2026 1.60M $136.30M Add
Q3 2026 1.60M $72.50M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 39 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$323.0M), Polar Capital Holdings Plc (US$227.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has Integral Health Asset Management, LLC held CYTK?

Integral Health Asset Management, LLC has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Integral Health Asset Management, LLC's current position in CYTK?

As of Q3 2026, Integral Health Asset Management, LLC holds 1.60M shares of CYTK (CYTOKINETICS INC), valued at $72.50M, representing 4.70% of its reported portfolio and ranking #3.

Has Integral Health Asset Management, LLC been buying or selling CYTK?

In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC held unchanged its position in CYTK. The position peaked in Q2 2026 at 1.60M shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, Polar Capital Holdings Plc, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.